« Previous Page: 1 of 11 Next »

Announcements Stay up to date.  Click here to subscribe to the Announcements RSS Feed


Changes to USMLE procedures for reporting scores - April 1, 2013

Posted: December 26, 2012
Updated: March 13, 2013

As previously reported, the USMLE program has begun the process of eliminating the reporting of results on the 2-digit score scale to parties other than the examinee and any state licensing authority to which the examinee sends results. This process began on July 1, 2011 with elimination of 2-digit scores from USMLE transcripts reported through ERAS.

The USMLE program will extend this change in reporting to include ALL score recipients (e.g., examinees, state medical boards). This means that scores on the 2-digit scale will no longer be calculated or reported. We expect to eliminate the 2-digit score effective April 1, 2013. This change pertains to the Step 1, Step 2 CK, and Step 3 examinations only; Step 2 CS will continue to be reported as pass or fail.

Background

Since its beginning in the 1990s, the USMLE program has reported two numeric scores for the Step 1, Step 2 CK, and Step 3 examinations, one on a 3-digit scale and one on a 2-digit scale. The 3-digit score scale is considered the primary reporting scale; it is developed in a manner that allows reasonable comparisons across time. The 2-digit scale is intended to meet statutory requirements of some state medical boards that rely on a score scale that has 75 as the minimum passing score. The process used to convert 3-digit scores to 2-digit scores is designed in such a way that the 3-digit minimum passing score in effect when the examinee tests is associated with a 2-digit score of 75.

The USMLE program requires its governing committees to reevaluate the minimum passing score for each Step every three to four years. This process has, at times, resulted in changes in the minimum passing score, expressed on the 3-digit scale, and an accompanying change in the score conversion process, to ensure that a 2-digit score of 75 is associated with the new minimum passing requirement. A by-product of the adjustment of the score conversion system over time has been a shift in the relationship between the two score scales. This shift has no impact for USMLE score users who use the 3-digit scoring scale or for those using the 2-digit scale with a primary interest in whether the examinee has a passing 2-digit score of at least 75. However, it may create challenges in interpretation for score users who are focusing on 2-digit scores, other than 75, and are doing so for purposes of comparing USMLE scores that span several years.

To eliminate confusion surrounding the 2-digit scale, the USMLE Composite Committee, the governing body of the USMLE program, directed staff to discontinue its reporting.


State board sponsorship for Step 3 discontinued

Posted: October 14, 2013
Updated: October 22, 2014

With the introduction of the restructured Step 3 examination in 2014, the USMLE program no longer requires examinees to apply for Step 3 under the eligibility requirements of a specific medical licensing authority.

All other Step 3 eligibility requirements (i.e., medical degree, passing Steps 1-2, ECFMG certification for IMGs) remain applicable, as do all other USMLE program requirements (e.g., no more than 6 attempts at a Step or a Step component).

Note: Removing state board sponsorship as part of the Step 3 examination application does not impact medical licensing requirements in the United States. Most medical licensing authorities have, and will continue to maintain, specific criteria for completion of the USMLE, such as time and attempt limits. A summary of these requirements can be found on the Federation of State Medical Boards website.

At this time, there are no plans for the USMLE program to impose a minimum residency training requirement as part of the Step 3 eligibility criteria. However, the USMLE program will likely continue to recommend that individuals take Step 3 at or near the completion of the first year of residency training.


A message about the Ebola outbreak for individuals scheduled to take USMLE Step 2 Clinical Skills (CS)

Posted: October 21, 2014

The United States Centers for Disease Control (CDC) has issued travel notices for several countries in connection with the Ebola Virus outbreak.   For the most current information concerning affected countries, please see http://wwwnc.cdc.gov/travel/diseases/ebola.

If you reside in or have recently traveled to any country subject to a travel notice, or if you might have come in contact with anyone with Ebola, and have concerns about your health and/or the health and safety of those with whom you might come in contact, you are strongly encouraged to contact your registering entity to reschedule your Step 2 CS examination, at no additional fee. Contact information is available at http://www.usmle.org/bulletin/communicating/.


« Previous Page: 1 of 11 Next »